Literature DB >> 17275069

Evaluation and performance characteristics of the automated coagulation analyzer ACL TOP.

Anny Appert-Flory1, Florence Fischer, Didier Jambou, Pierre Toulon.   

Abstract

INTRODUCTION: The ACL TOP is a fully-automated random-access multiparameter coagulation analyzer equipped with a photo-optical clot-detection unit. It is designed to perform coagulation, chromogenic and immunologic assays with continuous loading capabilities for samples, reagents and disposables.
MATERIALS AND METHODS: The instrument was evaluated in a coagulation laboratory of a university hospital with respect to its technical features in the determination of routine coagulation (prothrombin time, activated partial thromboplastin time, fibrinogen and single coagulation factor levels), chromogenic (anti-activated factor X, antithrombin and protein C activities) and immunologic assays (free protein S and von Willebrand factor antigen concentrations).
RESULTS: Using fresh and lyophilized plasma samples, the intra-assay and inter-assay coefficients of variation were below 5% for most of the parameters both in the normal and in the pathological ranges. For clotting assays performed at 671 nm, no significant interference could be demonstrated with hemolytic, icteric and lipemic samples as demonstrated by results similar to those obtained using a mechanical clot-detection-based analyzer (STAR). No sample carryover was detected in measuring alternatively heparinized (1.0 IU/mL unfractionated heparin) and normal plasma samples. The results of the different coagulation, chromogenic and immunologic assays obtained on the ACL TOP were well correlated with those obtained on the STAR analyzer with the correlation coefficient (r) in the range from 0.876 to 0.990.
CONCLUSIONS: Our results demonstrated that using the ACL TOP analyzer, routine hemostasis testing can be performed with satisfactory precision and the same applied to more specialized and specific tests such as single factor activity or antigen concentration.

Entities:  

Mesh:

Year:  2007        PMID: 17275069     DOI: 10.1016/j.thromres.2006.12.002

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Prediction of abdominal aortic aneurysm calcification by means of variation of high-sensitivity C-reactive protein.

Authors:  Emirena Garrafa; Alessio Giacomelli; Marco Ravanelli; Patrizia Dell'Era; Michele Peroni; Camilla Zanotti; Luigi Caimi; Stefano Bonardelli
Journal:  JRSM Cardiovasc Dis       Date:  2016-12-06

2.  Development and implementation of tPA clot lysis activity assay using ACL TOP™ hemeostasis testing system in QC laboratories.

Authors:  Lichun Huang
Journal:  Biotechnol Rep (Amst)       Date:  2017-10-27

3.  Utility of Clot Waveform Analysis in Russell's Viper Bite Victims with Hematotoxicity.

Authors:  Siju V Abraham; Aboobacker Mohamed Rafi; S Vimal Krishnan; Babu Urumese Palatty; Susheela J Innah; Jerry Johny; Salish Varghese
Journal:  J Emerg Trauma Shock       Date:  2018 Jul-Sep

4.  A Comparative Evaluation of an Automated Functional Assay for Von Willebrand Factor Activity in Type 1 Von Willebrand Disease.

Authors:  Shiue-Wei Lai; Chia-Yau Chang; Shin-Nan Cheng; Shu-Hsia Hu; Chung-Yu Lai; Yeu-Chin Chen
Journal:  Int J Gen Med       Date:  2021-09-02

5.  The Sysmex CS-5100 coagulation analyzer offers comparable analytical performance and excellent throughput capabilities.

Authors:  T Flieder; T Gripp; C Knabbe; I Birschmann
Journal:  Pract Lab Med       Date:  2016-09-21

6.  Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis.

Authors:  Tatiana Koudriavtseva; Annunziata Stefanile; Marco Fiorelli; Caterina Lapucci; Svetlana Lorenzano; Silvana Zannino; Laura Conti; Giovanna D'Agosto; Fulvia Pimpinelli; Enea Gino Di Domenico; Chiara Mandoj; Diana Giannarelli; Sara Donzelli; Giovanni Blandino; Marco Salvetti; Matilde Inglese
Journal:  Front Immunol       Date:  2020-10-27       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.